TI
DGX icon

Telemetry Investments’s Quest Diagnostics DGX Stock Holding History

Telemetry Investments’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-3,500
Closed -$328K – 140
2017
Q3 		$328K Buy
+3,500
New +$372K 0.12% 92
2015
Q2 		– Sell
-4,159
Closed -$320K – 185
2015
Q1 		$320K Buy
+4,159
New +$298K 0.18% 116

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $7.03B AUM 11.68% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Telemetry Investments's DGX Position: Q4 2017 in Review

Telemetry Investments sold out of Quest Diagnostics (DGX) in Q4 2017, closing a stake of 3,500 shares — an estimated $328K sold.

Telemetry Investments first reported a position in DGX in Q1 2015 and held it in 2 quarters. The position peaked at $328K in Q3 2017. 631 funds tracked by Wall St. Rank hold DGX as of Q4 2017.

  • Telemetry Investments reported no remaining Quest Diagnostics position as of Q4 2017 after selling out during the quarter.
  • Telemetry Investments sold 3,500 Quest Diagnostics shares in Q4 2017, an estimated $328K.
  • Telemetry Investments first reported a position in Quest Diagnostics in Q1 2015 and held it in 2 quarters.
  • Telemetry Investments's Quest Diagnostics position peaked at $328K in Q3 2017.
  • 631 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2017.

Based on Telemetry Investments's 13F filing for Q4 2017, filed 14 Feb 2018.